These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2896636

  • 1. The effect of levocabastine nasal spray in nasal provocation tests.
    Palma-Carlos AG, Palma-Carlos ML, Rombaut N.
    Int J Clin Pharmacol Res; 1988; 8(1):25-30. PubMed ID: 2896636
    [Abstract] [Full Text] [Related]

  • 2. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM.
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [Abstract] [Full Text] [Related]

  • 3. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S, Nielsen K, Bisgaard H, Mygind N.
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [Abstract] [Full Text] [Related]

  • 4. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C, Wagenmann M, Vossen-Holzenkamp S.
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [Abstract] [Full Text] [Related]

  • 5. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R, Pedersen B, Larsen B.
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [Abstract] [Full Text] [Related]

  • 6. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP.
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [Abstract] [Full Text] [Related]

  • 7. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
    Pécoud A, Zuber P, Kolly M.
    Int Arch Allergy Appl Immunol; 1987 Sep; 82(3-4):541-3. PubMed ID: 2883132
    [Abstract] [Full Text] [Related]

  • 8. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
    Corren J, Rachelefsky G, Spector S, Schanker H, Siegel S, Holton D, Karcher K, Travers S.
    J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx.
    Pazdrak K, Górski P, Ruta U.
    Allergy; 1993 Nov; 48(8):598-601. PubMed ID: 7906926
    [Abstract] [Full Text] [Related]

  • 10. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
    Kremer B, Tündermann A, Goldschmidt O.
    Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
    [Abstract] [Full Text] [Related]

  • 11. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
    Kolly M, Pécoud A.
    Br J Clin Pharmacol; 1986 Oct; 22(4):389-94. PubMed ID: 2876723
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA, Ruprecht KW.
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [Abstract] [Full Text] [Related]

  • 13. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K, Pipkorn U, Bake B, Blychert LO.
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [Abstract] [Full Text] [Related]

  • 14. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis.
    Anzic SA, Dzepina D, Kalogjera L.
    Eur Arch Otorhinolaryngol; 2007 Nov; 264(11):1309-14. PubMed ID: 17618447
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of levocabastine in perennial rhinitis].
    Pacor ML, Biasi D, Maleknia T, Carletto A, Lunardi C.
    Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
    [Abstract] [Full Text] [Related]

  • 16. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I, Jaúregui I, Basomba A, Cadahia A, Feo F, García JJ, Gonzalo MA, Luna I, Rubio M, Vázquez M.
    Allergol Immunopathol (Madr); 1998 Jun; 26(1):9-16. PubMed ID: 9585822
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC, Martin BG, Dolen J, Travers S, Karcher K, Holton D.
    Am J Rhinol; 1999 Jun; 13(1):55-62. PubMed ID: 10088031
    [Abstract] [Full Text] [Related]

  • 18. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P, Kaliner MA, Wheeler WJ.
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 20. [Ebastine : treatment of perennial rhinitis in the child].
    Benavente V, Eseverri JL, Botey J, Marin A.
    Allerg Immunol (Paris); 1996 Oct; 28(8):277-81. PubMed ID: 9011166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.